Please login to the form below

Not currently logged in
Email:
Password:

Pharmaceutical Market Europe - January 2016

PME January 2016

Welcome to your first PME of 2016, which in company terms has already started with a bang and the news of Shire’s acquisition of Baxalta for $32bn - coincidentally the same size as AbbVie’s offer for Shire last year, before US tax changes brought that deal crashing to a halt.

In addition to mergers - and asset swaps - this month we take a special look at some future trends in healthcare use of technology.

We also speak to Shire’s international lead for neuroscience Alvaro Herreros, who talked to us about working with patients with ADHD and his firm’s application of technology to that therapy area.

There’s also another exclusive interview, this time with the UK’s chief medical advisor Professor Dame Sally Davies on the growing and very real danger in Europe and beyond posed by antimicrobial resistance.

And if the predictions contained in our cover feature on the rising global use of medicines prove to be correct then the industry is shaping up for a strong couple of years, provided pricing and market access hurdles can be overcome.

With further strong signs seen in new product approvals, which last year scaled a 19-year high in the US, 2016 is already shaping up to be quite a year.

Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.

PME is also available to download as an app for iPhone and iPad

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Infographics